Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-01

Clinical Trial Update: Evaluating the Feasibility of Acapella® Choice as a Dysphonia Treatment [NA]

View source ↗

Summary

A completed clinical trial evaluating Acapella Choice for treating dysphonia, with results posted in 2023. No efficacy conclusions provided here.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acapella Choice

Snippet

Sponsor: University College, London | Conditions: Muscle Tension Dysphonia, Vocal Fold Palsy | NA | Status: COMPLETED | Results posted: 2023-08-01